J-Lex

Arixtra subcutaneous injection 7.5mg

Arixtra subcutaneous injection 7.5mg, manufactured by Sand Pharma, contains Fondaparinux sodium, a synthetic anticoagulant used to prevent and treat various thromboembolic disorders. It is an injectable medication with a YJ code of 3339400G4028 and a standard of 7.5 mg in 0.6 mL per tube.

← Back to search

Need more detailed information?

Contact TASAKI PHARMA for inquiries about this medicine (English support available).

Contact us about this drug →

More with the same ingredient

More from this manufacturer